Withdrawal Notice
This paper was originally published in Oncotarget Advance Online Publications on 12/25/2017.In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.
Research Papers:
NNK promotes chronic pancreatitis to pancreatic intraepithelial neoplasia and accelerates pancreatic cancer migration
Xin Chen1,*, Liang Sheng1,*, Jiguang Ma2, Zhengdong Jiang1,Qinhong Xu1, Jianjun Lei1, Wanxing Duan1, Ligang Nan1, Xuqi Li3, Zheng Wang1, Zheng Wu1, Jun Xu1, Fengfei Wang4,5,6,7, Jason H. Huang4,6,7, Erxi Wu4,6,7,8, Qingyong Ma1 and Dong Zhang1
1 The Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
2 The Department of Anesthesiology, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
3 The Department of General Surgery, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
4 Department of Neurosurgery, Baylor Scott & White Health, Temple, TX, USA
5 Department of Neurology, Baylor Scott & White Health, Temple, TX, USA
6 Neuroscience Institute, Baylor Scott & White Health, Temple, TX, USA
7 Department of Surgery, Texas A & M University College of Medicine, Temple, TX, USA
8 Department of Pharmaceutical Sciences, Texas A & M University College of Pharmacy, College Station, TX, USA
* These authors have contributed equally to this work
Correspondence to:
Erxi Wu, email: [email protected]
Qingyong Ma, email: [email protected]
Dong Zhang, email: [email protected]
Keywords: 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; sonic hedgehog pathway; chronic pancreatitis; pancreatic cancer
Received: October 21, 2017 Accepted: December 11, 2017 Epub: December 25, 2017
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23669